Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and …

CC Chang, S Omarjee, A Lim, T Spelman… - The Journal of …, 2013 - academic.oup.com
Background. Human immunodeficiency virus–infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …
被引用次数：88 相关文章

[引用][C] Chemokine Levels and Chemokine Receptor Expression in the Blood and the Cerebrospinal Fluid of HIV-Infected Patients With Cryptococcal Meningitis and …

CC CHANG, S OMARJEE, SR LEWIN… - The Journal of …, 2013 - pascal-francis.inist.fr
Chemokine Levels and Chemokine Receptor Expression in the Blood and the
Cerebrospinal Fluid of HIV-Infected Patients With Cryptococcal Meningitis and …

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and …

CC Chang, S Omarjee, A Lim… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Human immunodeficiency virus-infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and …

CC Chang, S Omarjee, A Lim, T Spelman… - The Journal of …, 2013 - europepmc.org
Background Human immunodeficiency virus-infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …
[PDF] researchgate.net

[PDF][PDF] MAJOR ARTICLE

CC Chang, S Omarjee, A Lim, T Spelman… - The Journal of …, 2013 - researchgate.net
Background. Human immunodeficiency virus–infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …
[PDF] psu.edu

[PDF][PDF] Journal of Infectious Diseases Advance Access published September 18, 2013

CC Chang, S Omarjee, A Lim, T Spelman, BI Gosnell… - 2013 - Citeseer
Background. Human immunodeficiency virus–infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …
[HTML] nih.gov

[HTML][HTML] Chemokine Levels and Chemokine Receptor Expression in the Blood and the Cerebrospinal Fluid of HIV-Infected Patients With Cryptococcal Meningitis and …

CC Chang, S Omarjee, A Lim, T Spelman… - The Journal of …, 2013 - ncbi.nlm.nih.gov
Background. Human immunodeficiency virus–infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …

Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and …

CC Chang, S Omarjee, A Lim… - Journal of …, 2013 - research-repository.uwa.edu.au
Background. Human immunodeficiency virus-infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …
[PDF] academia.edu

[PDF][PDF] MAJOR ARTICLE

CC Chang, S Omarjee, A Lim, T Spelman… - The Journal of …, 2013 - academia.edu
Background. Human immunodeficiency virus–infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …

Chemokine Levels and Chemokine Receptor Expression in the Blood and the Cerebrospinal Fluid of HIV-Infected Patients With Cryptococcal Meningitis and …

CC Chang, S Omarjee, A Lim… - Journal of Infectious …, 2013 - search.ebscohost.com
Background. Human immunodeficiency virus–infected patients with treated cryptococcal
meningitis who start combination antiretroviral therapy (cART) are at risk of further …